The mission of the lab is to pioneer therapies for retinal degeneration and dementia, acquire leadership in providing high quality invitro and invivo and alternative efficacy facilities for preclinical evaluation of industrial drugs, herbs and biotherapeutics, expand molecular biomarker discovery program for neurological disorders and train graduate students in latest cellular, molecular, electrophysiological and behavioral techniques.